Literature DB >> 23553575

Methylphenidate and atomoxetine for treatment of nocturnal enuresis in a child with attention-deficit hyperactivity disorder.

Kayhan Bahali1, Hamiyet Ipek, Ozden Sükran Uneri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23553575     DOI： 10.1007/s00787-013-0414-x

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN： 1018-8827            Impact factor:   4.785


× No keyword cloud information.
  9 in total

1.  Clinical case rounds in child and adolescent psychiatry: enuresis and ADHD in older children and an adolescent treated with stimulant medication: a case series.

Authors:  Lloyda B Williamson; Michael Gower; Thaddeus Ulzen
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2011-02

2.  Placebo-controlled study of the effects of atomoxetine on bladder control in children with nocturnal enuresis.

Authors:  Calvin R Sumner; Kory J Schuh; Virginia K Sutton; Robert Lipetz; Douglas K Kelsey
Journal:  J Child Adolesc Psychopharmacol       Date:  2006-12       Impact factor: 2.576

3.  Atomoxetine for the treatment of pediatric nocturnal enuresis.

Authors:  Jess P Shatkin
Journal:  J Child Adolesc Psychopharmacol       Date:  2004       Impact factor: 2.576

4.  Enuresis in children with attention-deficit hyperactivity disorder.

Authors:  W L Robson; H P Jackson; D Blackhurst; A K Leung
Journal:  South Med J       Date:  1997-05       Impact factor: 0.954

Review 5.  Practice parameter for the assessment and treatment of children and adolescents with enuresis.

Authors:  Gregory Fritz; Randy Rockney; William Bernet; Valerie Arnold; Joseph Beitchman; R Scott Benson; Oscar Bukstein; Joan Kinlan; Jon McClellan; David Rue; Jon A Shaw; Saundra Stock; Kristin Kroeger Ptakowski
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2004-12       Impact factor: 8.829

6.  Clinical correlates of enuresis in ADHD and non-ADHD children.

Authors:  J Biederman; S L Santangelo; S V Faraone; K Kiely; J Guite; E Mick; E D Reed; I Kraus; M Jellinek; J Perrin
Journal:  J Child Psychol Psychiatry       Date:  1995-07       Impact factor: 8.982

7.  Management of urinary incontinence and nocturnal enuresis in attention-deficit hyperactivity disorder.

Authors:  C R Crimmins; S R Rathbun; D A Husmann
Journal:  J Urol       Date:  2003-10       Impact factor: 7.450

8.  A survey of voiding dysfunction in children with attention deficit-hyperactivity disorder.

Authors:  Barry P Duel; Robin Steinberg-Epstein; Maryann Hill; Marc Lerner
Journal:  J Urol       Date:  2003-10       Impact factor: 7.450

9.  European guidelines on managing adverse effects of medication for ADHD.

Authors:  J Graham; T Banaschewski; J Buitelaar; D Coghill; M Danckaerts; R W Dittmann; M Döpfner; R Hamilton; C Hollis; M Holtmann; M Hulpke-Wette; M Lecendreux; E Rosenthal; A Rothenberger; P Santosh; J Sergeant; E Simonoff; E Sonuga-Barke; I C K Wong; A Zuddas; H-C Steinhausen; E Taylor
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-11-03       Impact factor: 4.785
  9 in total
  4 in total

1.  Optimising the management of children with concomitant bladder dysfunction and behavioural disorders.

Authors:  Dilharan D Eliezer; Christopher Lam; Angela Smith; John Mithran Coomarasamy; Naeem Samnakay; Malcolm R Starkey; Aniruddh V Deshpande
Journal:  Eur Child Adolesc Psychiatry       Date:  2022-06-29       Impact factor: 5.349

2.  Impaired selective attention in patients with severe primary monosymptomatic nocturnal enuresis: An event-related potential study.

Authors:  Mohamed N Thabit; Ahmed M Abd Elhamed
Journal:  Clin Neurophysiol Pract       Date:  2021-10-07

Review 3.  Comorbidity of ADHD and incontinence in children.

Authors:  Alexander von Gontard; Monika Equit
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-07-01       Impact factor: 4.785

4.  Associations Between Psychiatric Disorders and Enuresis in Taiwanese Children: A National Population-Based Study.

Authors:  Hsin-Lin Tsai; Jei-Wen Chang; Mu-Hong Chen; Mei-Jy Jeng; Ling-Yu Yang; Keh-Gong Wu
Journal:  Clin Epidemiol       Date:  2020-02-18       Impact factor: 4.790
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.